For years, the conversation around medical treatments for obesity and type 2 diabetes has revolved around injectables such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Now, the future may fit inside a pill.

Aug, 2025. For years, the market for alternative sweeteners has grown rapidly, fueled by the search for healthier options to replace traditional sugar. Among them, allulose has generated special interest not only because it contains virtually no calories, but also because of its metabolic effects. A recent study published in PLOS ONE analyzed the available evidence and concluded that this rare sugar can help reduce blood glucose levels after meals, even in healthy individuals.

The quest for safer and more effective therapies for pancreatic cancer has led researchers in Hiroshima to explore an unexpected avenue: a common natural sweetener, transformed through fermentation into a compound with selective cytotoxicity against cancer cells. They set out with a simple idea—enhance a stevia extract by fermentation to release a compound that targets malignant cells.

Are potatoes really to blame for type 2 diabetes? A new large-scale study published in The BMJ followed more than 200,000 people for several years to uncover how different types of potato consumption affect the risk of developing the disease.

For decades, cholesterol was considered the ultimate threat to heart health. But a groundbreaking 15-year study published in JAMA Internal Medicine has shifted the narrative: too much added sugar may be even deadlier for the heart than cholesterol itself.

Starting in 2026, twelve U.S. states will ban the purchase of soda, candy, energy drinks, and other sugary products with SNAP benefits, commonly known as food stamps. This marks a historic shift in nutrition policy, as the program has long avoided restrictions on what families could buy.

A new clinical trial from the National Institutes of Health (NIH) is asking an intriguing question: if mothers eat peanuts and eggs during pregnancy and breastfeeding, could this lower the chances of their babies developing food allergies?

Sucralose, one of the most popular artificial sweeteners found in low-calorie products, could have a negative impact on cancer treatment, according to a recent study. This finding emphasizes the importance of being aware of what we consume, especially when facing serious diseases like cancer.

The third edition of Fat to Fit the Healthy Mag has officially launched on Amazon, featuring the powerful cover theme “Eat to Be Happy.” This new release invites readers to explore the transformative connection between nutrition and emotional well-being, offering science-based guidance on how food can actively support the production of serotonin, dopamine, and other feel-good hormones.

When we picture eating disorders, we usually think of willpower battles and calorie counts. A new review in Nutrients flips that script, pointing to the microbiome as a silent but powerful player. Italian researchers report that women with anorexia, bulimia or binge-eating disorder carry a distinct microbial “fingerprint” —less diverse, skewed toward bacteria that tweak neurotransmitters, appetite hormones and gut permeability— and argue these shifts may help spark and sustain the illness rather than merely reflect it.

If you’re on keto or just looking for a sugar swap that truly works, D-allulose could be the game-changer you didn’t know you needed. This rare, low-calorie sugar has been gaining momentum as a sweetener, but the key question is: does it mess with your gut bacteria or cause digestive troubles like so many others?

Oscar Mayer, one of the most recognized brands in deli meats, has just announced a recall that should catch consumers’ attention: its pre-cooked turkey bacon may be contaminated with Listeria monocytogenes. According to the U.S. Department of Agriculture (USDA) and reported by Consumer Reports, Kraft Heinz is voluntarily recalling roughly 20,000 packages of its ready-to-eat turkey bacon as a precaution.